Others have shown by NMR spectroscopy that ischaemia produces a degradation of phosphocreatine (PCr) and ATP. We tested the feasibility of NMR spectroscopy for gaining kinetic data on the degradation of PCr and ATP at different body temperatures.
C respectively. NMR spectra of 31P phosphates were recorded using a 1.9 Tesla. 24 cm bore superconducting magnet. Degradation kinetics of the compounds were measured after cardiac arrest at 35O. 24 O and 21°. The decay of PCr and ATP followed a single exponential function, indicating first order kinetics. The half time values (T/2) are given in the table (4 animals per temperature; SO) 35°C 24OC 2 P C TI2 PCr (min) 1 9 t 8 4 B t 6 6 3 + 1 9 T/2 ATP (min) 35 t 10 69 t 10 112 t 19 s em per at ire ' dependency follows the Arrhenius law for chemical kinetics. From the Arrhenius plot the activation energies were calculated to be 16.7 t 2.8 kcal/mol for PCr and 14.6 t 2.1 kcal/mol for ATP. These energies are typical for enzyme catalyzed reactions.
Our data show that in situ NMR spectroscopy can be used to study the kinetics of degradation of high energy phosphates. This method could be used to investigate how far hypothermia can protect the brain during operations in circulatory arrest and deep hypothermia. Cardiocytes of h m atria possess granules similar to those of endocrine glands. %ese granules wntain polypeptides with potent natriuretic and vasorelaxing pmperties (atrial natriuretic peptide = ANP) .
The presence of ANP in circulating blmd has not yet been h n s t r ated in h m peripheral b l d . Using a specific and sensitive radioimmmassay, we were able to de tect and guantitate ANP in plasm of normal children (n=51) and of children with cardiovascular diseases (n=18). In n o m l children, the -ANP plasm wnoentration was 27.5 h l / m l (range 1 -45.5 h 1 / ml). There was no significant difference of ANP-levels between infants (n=12) and older children (n=39). H o d e v e r , in patients with cardiovascular diseases such as congenital heart malfomtions a d bronchopulm n q dysplasia, ANP-levels were up to 20 times higher (wan 162.7 hl/ml; range 37 -537 hl/ml) when m n p~e d with the m value in n o d children. 15 out of 18 patients exceeded the upper range of ANP-levels in controls. Furthenmre, in critically ill children (n=3), ANP-levels were markedly higher at the tirre of hospital aCbnission (range 92.5 -266.6 hl/ml) than after therapy (range 25.8 -55.1 hl/ml) . In accordance to observations in experimental aninnls, o w findings suggest that atrial distension caused the increased ANP-release in our patients with cardiac diseases. Wdsurewnt of ANP-levels may be a useful tool to assess circulatoq status in cardiac diseases.
Abnormalities at a cellular level in relation to the phore and by D 6-were significantly greater in the asthmatics than in the heal thy su&ects (P'0.05 and P'0.025 respectively). Between patients with pronounced and limited BhR the histamine release but not the 02-generation was significantly different (P'0.025). In study I1
cal ci um i nf 1 ux, change in membrane potenti a1 and histamine re1 ease after anti-IgE, Ca ionophore and D20 were measured in a suspension of basophil s, selected by a fluorescence activated cell sorter. (Purity 60%. recovery 20%, high reproducibility). Results of study I and preliminary results of study I1 suggest a basic intracellular abnormal i ty in asthma and BHR. After preliminary characterization of C3 converting factor (C3 CoF) the question was raised whether this factor was a "true" activator of C3, i.e. generates C3a and C3b on interaction with native C3. For this purpose C3 NeF and C3 CoF activity were separated from each other by euglobulin precipitation and anion exchange chromatography using a discontinuous salt gradient. The C3 CoF containing fraction was devoid IgG. To identify the site of cleavage in the C3 molecule C3 was isolated from normal human serum to apparent homogeneity and radiolabelled with 125-iodine using the Bolten-Hunter method. Incubation of this radiolabelled C3 with C3 CoF isolated from patient's serum generated two major C3 fragments identified by autoradiography following SDS-PAGE under reducing conditions: A large fragment with 117 kD and a small fragment with approx. 10 kD. Following autoradiography proteins were transblotted on nitrocellulose and analyzed for expression of C3 antigens using the Western blot technique and monospecific antisera to C3a and C3c. The 117 kD fragment expressed C3c antigen but no C3a antigen, the 10 kD fragment expressed C3a antigen only indicating that C3 was, indeed, cleaved into C3a and C3b. We conclude that C3 CoF is a "true" activator of C3. The generation of the peripheral T-cell pool is attributed to maturation and differentiation events occurring within the thymus. Three thymic compartments, thymic epithelial cells, thymic hormons and thymic M& are considered to contribute to the intrathymic T-cell developnent. While, as we have shown earlier, murine as well as human MHC-Ia-negative-K$ (I~-M&) regulate thymocyte (TH) differentiation via suppressive effects (Thymus, 6:295,1984 ) and MHC-1a+-K$ are involved in intrathymic tolerance induction (Pediatr Res,15:800,1984) , now the contribution of I~+M& to intrathymic lymphopiesis was investigated. An isolation method yielding cell suspensions highly enriched for 1a+ thymic Md was performed (PA-gradient , antibody treatment, irradiation).
PROMOTICN OF IWIRATHYMIC T-CELL
Cocultivation of these Ia M& wlth TH showed that 1a+Md strongly augmented the mitogen-induced proliferation of TH by about 200%. The effect was dependent on the number of 1a+M added Kd on the degree of TH maturity: stronger augmentation occurred at higher M& concentrations) immature TH s h o d highest susceptibility to the I~+M& mediated effect. Cell-cell-contact was an important prerequisite for the proliferation amplifying effect as demonstrated by use of Cytochalasin B. In addition, humoral factors produced by 1a+M also improved the proliferative capacity of TH, similar to results obtained using interleukin 11. The results described support the view that thymic M& poqulations act as a main regulatory principle in T-cell developnent. Ia M& augment in5rathymic lymphopiesis and participate in tolerance induction,while Ia control the number of TH finally leaving the thymus gland.
-;yyf" LDCF) and desoxyadenosine ( Dividing as well as resting T cells are sensitive to p4 concentrations of d m in the presence of an adenosine-deaminase (ADA) inhibitor such as DCF. Therefore, this drug combination was investigated for its ability to deplete T cells from allogeneic rat bone marrow (EM) and spleen (SP) cells and for its potential to prevent G W D in fully allogeneic rat bone marrow transplantationLBMT), -It was found that a concentration of 0.5 Cul of DcF was sufficient to block ADA-activity in rat BM and SP cells completely. Concentrations as high as 100 p4 were not toxic to in vitro colony forming units (CFU-GM). Iqcreasing dADO concentrations in the presence of DCF led to increasing T cell but also increasing CFU toxicity. However, dADO concentrations below 40 p4 had no significant influence on CFU growth but clearly exhibited an effect on T cells. T cell functions, as determined by mitogen and alloantigen stimulated thymidine (3HTdR) uptake, were reduced to 10-30% of normal values. Flowcytometric analysis revealed a significant T cell reduction following in vitro treatment. However, some residual T cells were detectable in treated samples. -In accordance with the described in vitro data, rat-recipients of DCF/dACO treated allogeneic BM and SP cell grafts showed a significantly decreased incidence of acute lethal WED. -The results indicate that a significant but incomplete depletion of T cells can be achieved through DCF/dADO in vitro treatment using concentrations which are not toxic for stem cells. Such T cell depletion results in modification of acute lethal G W D into a chronic form in fully allogeneic rat BMT.
